Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
23/04/2015 | 23:00 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:SNTS | Santarus, Inc. (MM) |
02/04/2015 | 23:00 | Edgar (US Regulatory) | Withdrawal of Registration Statement (rw) | NASDAQ:SNTS | Santarus, Inc. (MM) |
17/02/2015 | 16:01 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SNTS | Santarus, Inc. (MM) |
30/05/2014 | 23:03 | Edgar (US Regulatory) | Securities Registration: Business Combination (s-4) | NASDAQ:SNTS | Santarus, Inc. (MM) |
14/02/2014 | 22:21 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SNTS | Santarus, Inc. (MM) |
31/12/2013 | 17:50 | Zacks | Pipeline Setback at Can-Fite BioPharma, Shares Down - Analyst Blog | NASDAQ:SNTS | Santarus, Inc. (MM) |
30/12/2013 | 13:00 | Business Wire | Santarus Announces Availability of Amended Tender Offer Materials | NASDAQ:SNTS | Santarus, Inc. (MM) |
28/12/2013 | 01:00 | Zacks | Durata Progresses with Dalbavancin - Analyst Blog | NASDAQ:SNTS | Santarus, Inc. (MM) |
23/12/2013 | 23:32 | PR Newswire (US) | G-III Apparel Group Set to Join the S&P SmallCap 600 | NASDAQ:SNTS | Santarus, Inc. (MM) |
23/12/2013 | 13:00 | Business Wire | Santarus Initiates Phase IIa Study with SAN-300 in Patients with Active Rheumatoid Arthritis | NASDAQ:SNTS | Santarus, Inc. (MM) |
03/12/2013 | 10:28 | Zacks | Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook | NASDAQ:SNTS | Santarus, Inc. (MM) |
03/12/2013 | 10:28 | Zacks | Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews | NASDAQ:SNTS | Santarus, Inc. (MM) |
15/11/2013 | 23:00 | Zacks | Update on Questcor's Portfolio - Analyst Blog | NASDAQ:SNTS | Santarus, Inc. (MM) |
15/11/2013 | 15:01 | Dow Jones News | HBK Investments LP 3Q 13F: Holdings As Of Sep 30 | NASDAQ:SNTS | Santarus, Inc. (MM) |
15/11/2013 | 15:01 | Dow Jones News | HBK Investments LP 3Q 13F: Holdings As Of Sep 30 -2- | NASDAQ:SNTS | Santarus, Inc. (MM) |
15/11/2013 | 14:39 | Dow Jones News | Kingdon Capital Management 3Q 13F: Largest Eliminations | NASDAQ:SNTS | Santarus, Inc. (MM) |
15/11/2013 | 14:39 | Dow Jones News | Kingdon Capital Management 3Q 13F: Holdings As Of -2- | NASDAQ:SNTS | Santarus, Inc. (MM) |
15/11/2013 | 14:39 | Dow Jones News | Kingdon Capital Management 3Q 13F: Holdings As Of Sep 30 | NASDAQ:SNTS | Santarus, Inc. (MM) |
12/11/2013 | 12:30 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SNTS | Santarus, Inc. (MM) |
11/11/2013 | 22:15 | PR Newswire (US) | Morgan & Morgan Announces the Investigation of Santarus, Inc. | NASDAQ:SNTS | Santarus, Inc. (MM) |
11/11/2013 | 17:31 | PR Newswire (US) | Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc. | NASDAQ:SNTS | Santarus, Inc. (MM) |
09/11/2013 | 03:10 | PR Newswire (US) | Harwood Feffer LLP Announces Investigation of Santarus, Inc. | NASDAQ:SNTS | Santarus, Inc. (MM) |
08/11/2013 | 23:21 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:SNTS | Santarus, Inc. (MM) |
08/11/2013 | 22:36 | PR Newswire (US) | Santarus, Inc. and Salix Pharmaceuticals, Ltd. Merger May Not Be in Santarus, Inc. Shareholders' Best Interests | NASDAQ:SNTS | Santarus, Inc. (MM) |
08/11/2013 | 22:35 | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:SNTS | Santarus, Inc. (MM) |
08/11/2013 | 22:24 | Business Wire | Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Santarus, Inc. Stockholders | NASDAQ:SNTS | Santarus, Inc. (MM) |
08/11/2013 | 19:38 | Business Wire | Law Offices of Howard G. Smith Announces Investigation of Santarus Inc. | NASDAQ:SNTS | Santarus, Inc. (MM) |
08/11/2013 | 18:36 | Business Wire | Wolf Haldenstein Announces Investigation of Acquisition of Santarus, Inc. | NASDAQ:SNTS | Santarus, Inc. (MM) |
08/11/2013 | 18:35 | PR Newswire (US) | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of San... | NASDAQ:SNTS | Santarus, Inc. (MM) |
08/11/2013 | 17:32 | Business Wire | Santarus Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Salix Pharma | NASDAQ:SNTS | Santarus, Inc. (MM) |